You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 020785


✉ Email this page to a colleague

« Back to Dashboard


NDA 020785 describes THALOMID, which is a drug marketed by Bristol-myers and is included in one NDA. It is available from one supplier. Additional details are available on the THALOMID profile page.

The generic ingredient in THALOMID is thalidomide. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the thalidomide profile page.
Summary for 020785
Tradename:THALOMID
Applicant:Bristol-myers
Ingredient:thalidomide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020785
Medical Subject Heading (MeSH) Categories for 020785
Suppliers and Packaging for NDA: 020785
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALOMID thalidomide CAPSULE;ORAL 020785 NDA Celgene Corporation 59572-205 59572-205-94 10 BLISTER PACK in 1 BOX (59572-205-94) / 28 CAPSULE in 1 BLISTER PACK (59572-205-14)
THALOMID thalidomide CAPSULE;ORAL 020785 NDA Celgene Corporation 59572-205 59572-205-97 10 BLISTER PACK in 1 BOX (59572-205-97) / 1 CAPSULE in 1 BLISTER PACK (59572-205-17)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Jul 16, 1998TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Jan 17, 2003TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Jan 17, 2003TE:RLD:Yes

Expired US Patents for NDA 020785

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol-myers THALOMID thalidomide CAPSULE;ORAL 020785-002 Jan 17, 2003 ⤷  Try a Trial ⤷  Try a Trial
Bristol-myers THALOMID thalidomide CAPSULE;ORAL 020785-004 Jan 10, 2007 ⤷  Try a Trial ⤷  Try a Trial
Bristol-myers THALOMID thalidomide CAPSULE;ORAL 020785-001 Jul 16, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.